Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemiafor Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeDrug: Ruxolitinib3 locations incl. ColumbusSponsor: Jennifer SaultzSex: All·Age: 18+Code: NCT03874052·Phase 1·RecruitingApply to this trial
Targeted Pathway Inhibition in Patients With Pancreatic Cancerfor Locally Advanced Pancreatic Ductal Adenocarcinoma1 location in PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 18+Code: NCT04005690·EARLY_Phase 1·RecruitingApply to this trial
Feasibility of FMISO in Brain Tumorsfor Malignant Brain Neoplasm1 location in PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 18+Code: NCT03649880·Phase 2·RecruitingApply to this trial
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous Systemfor Central Nervous System Neoplasm1 location in PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 10+Code: NCT03270059·Phase 2·RecruitingApply to this trial
Quantitative MRI Assessment of Breast Cancer Therapy Responsefor Breast Cancer4 locations incl. Iowa CitySponsor: Corewell Health EastSex: All·Age: 18+Code: NCT05704062·RecruitingApply to this trial
Pathogenesis of Hematologic Malignanciesfor Acute Leukemia1 location in PortlandSponsor: OHSU Knight Cancer InstituteSex: All·Age: 1+Code: NCT01728402·Enrolling By Invitation